165 related articles for article (PubMed ID: 9894724)
1. Clinical and economic analysis of allogeneic peripheral blood progenitor cell transplants: a Canadian perspective.
Couban S; Dranitsaris G; Andreou P; Price S; Tinker L; Foley R; Walker IR; Jamal S; Jamal N; Spaner D; Lipton J; Meharchand J; Messner HA
Bone Marrow Transplant; 1998 Dec; 22(12):1199-205. PubMed ID: 9894724
[TBL] [Abstract][Full Text] [Related]
2. [Collection of hematopoietic progenitor cells from healthy donors].
Bojanić I; Cepulić BG; Mazić S
Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
[TBL] [Abstract][Full Text] [Related]
3. [A pilot study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for malignant hematological diseases].
Chen Y; Huang X; Xu L; Liu D; Zhang Y; Ren H; Guo N; Lu D
Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1306-9. PubMed ID: 12509932
[TBL] [Abstract][Full Text] [Related]
4. Enhanced antileukemic activity of allogeneic peripheral blood progenitor cell transplants following donor treatment with the combination of granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF) in a murine transplantation model.
Hartung G; Zeis M; Glass B; Dreger P; Steinmann J; Schmitz N; Uharek L
Bone Marrow Transplant; 2003 Jul; 32(1):49-56. PubMed ID: 12815478
[TBL] [Abstract][Full Text] [Related]
5. A pilot study of allogeneic bone marrow transplantation using related donors stimulated with G-CSF.
Isola LM; Scigliano E; Skerrett D; Shank B; Ross V; Najfeld V; Fruchtman S
Bone Marrow Transplant; 1997 Dec; 20(12):1033-7. PubMed ID: 9466275
[TBL] [Abstract][Full Text] [Related]
6. Comparison between once a day vs twice a day G-CSF for mobilization of peripheral blood progenitor cells (PBPC) in normal donors for allogeneic PBPC transplantation.
Arbona C; Prosper F; Benet I; Mena F; Solano C; Garcia-Conde J
Bone Marrow Transplant; 1998 Jul; 22(1):39-45. PubMed ID: 9678794
[TBL] [Abstract][Full Text] [Related]
7. Reduced risk of acute GVHD following mobilization of HLA-identical sibling donors with GM-CSF alone.
Devine SM; Brown RA; Mathews V; Trinkaus K; Khoury H; Adkins D; Vij R; Sempek D; Graubert T; Tomasson M; Goodnough LT; DiPersio JF
Bone Marrow Transplant; 2005 Sep; 36(6):531-8. PubMed ID: 16025152
[TBL] [Abstract][Full Text] [Related]
8. Use of concurrent G-CSF + GM-CSF vs G-CSF alone for mobilization of peripheral blood stem cells in children with malignant disease.
Madero L; González-Vicent M; Molina J; Madero R; Quintero V; Díaz MA
Bone Marrow Transplant; 2000 Aug; 26(4):365-9. PubMed ID: 10982281
[TBL] [Abstract][Full Text] [Related]
9. Long-term engraftment, graft-vs.-host disease, and immunologic reconstitution after experimental transplantation of allogeneic peripheral blood cells from G-CSF-treated donors.
Pan L; Bressler S; Cooke KR; Krenger W; Karandikar M; Ferrara JL
Biol Blood Marrow Transplant; 1996 Oct; 2(3):126-33. PubMed ID: 9199755
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: a retrospective analysis.
Bornhäuser M; Theuser C; Soucek S; Hölig K; Klingebiel T; Blau W; Fauser A; Runde V; Schwinger W; Rutt C; Ehninger G
Haematologica; 2000 Aug; 85(8):839-47. PubMed ID: 10942931
[TBL] [Abstract][Full Text] [Related]
11. [CD34+ cell dose and hematologic recovery in allogeneic peripheral blood stem cell transplantation].
Sawada H; Wake A; Yamasaki Y; Izumi Y
Rinsho Ketsueki; 2000 Jun; 41(6):500-6. PubMed ID: 10921350
[TBL] [Abstract][Full Text] [Related]
12. GM-CSF-based mobilization effect in normal healthy donors for allogeneic peripheral blood stem cell transplantation.
Sohn SK; Kim JG; Seo KW; Chae YS; Jung JT; Suh JS; Lee KB
Bone Marrow Transplant; 2002 Jul; 30(2):81-6. PubMed ID: 12132046
[TBL] [Abstract][Full Text] [Related]
13. Administration of erythopoietin and granulocyte colony-stimulating factor in donor/recipient pairs to collect peripheral blood progenitor cells (PBPC) and red blood cell units for use in the recipient after allogeneic PBPC transplantation.
Sautois B; Baudoux E; Salmon JP; Michaux S; Schaaf-Lafontaine N; Pereira M; Paulus JM; Fillet G; Beguin Y
Haematologica; 2001 Nov; 86(11):1209-18. PubMed ID: 11694408
[TBL] [Abstract][Full Text] [Related]
14. Mobilization of peripheral blood progenitor cells (PBPC) in patients undergoing chemotherapy followed by autologous peripheral blood stem cell transplant (SCT) for high risk breast cancer (HRBC).
Benet I; Prosper BF; Marugan I; Lluch A; Arbona C; Castillo I; Solano C; Garcia-Conde J
Bone Marrow Transplant; 1999 Jun; 23(11):1101-7. PubMed ID: 10382948
[TBL] [Abstract][Full Text] [Related]
15. A randomized trial of granulocyte colony-stimulating factor (Neupogen) starting day 1 vs day 7 post-autologous stem cell transplantation.
Bence-Bruckler I; Bredeson C; Atkins H; McDiarmid S; Hamelin L; Hopkins H; Perry G; Genest P; Huebsch L
Bone Marrow Transplant; 1998 Nov; 22(10):965-9. PubMed ID: 9849693
[TBL] [Abstract][Full Text] [Related]
16. Cytokine-mobilized allogeneic peripheral blood stem cell transplants in children result in rapid engraftment and a high incidence of chronic GVHD.
Levine JE; Wiley J; Kletzel M; Yanik G; Hutchinson RJ; Koehler M; Neudorf S
Bone Marrow Transplant; 2000 Jan; 25(1):13-8. PubMed ID: 10654008
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and toxicity of a high-dose G-CSF schedule for peripheral blood progenitor cell mobilization in healthy donors.
Martínez C; Urbano-Ispizua A; Marín P; Merino A; Rovira M; Carreras E; Montserrat E
Bone Marrow Transplant; 1999 Dec; 24(12):1273-8. PubMed ID: 10627634
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic blood cell transplants for haematological malignancy: preliminary comparison of outcomes with bone marrow transplantation.
Russell JA; Brown C; Bowen T; Luider J; Ruether JD; Stewart D; Chaudhry A; Booth K; Jorgenson K; Coppes MJ; Turner AR; Larratt L; Desai S; Poon MC; Klassen J
Bone Marrow Transplant; 1996 May; 17(5):703-8. PubMed ID: 8733685
[TBL] [Abstract][Full Text] [Related]
19. Low incidence of severe aGVHD and accelerating hemopoietic reconstitution in allo-BMT using lenograstim stimulated BM cells.
Ji S; Chen H; Wang H; Ma J; Pan S; Xue M; Zhu L; Liu J; Xiao M; Zhou L
Chin Med J (Engl); 2001 Feb; 114(2):191-5. PubMed ID: 11780205
[TBL] [Abstract][Full Text] [Related]
20. Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim.
Weaver CH; Schulman KA; Buckner CD
Bone Marrow Transplant; 2001 May; 27 Suppl 2():S23-9. PubMed ID: 11436117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
